Press Releases

Press Releases

DiaSorin and MeMed Partner to Develop and Commercialize Novel Host Immune Response Based Diagnostic Solution

September 8, 2020

Prospective Study Finds Potential Utility of MeMed's Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients

July 23, 2020

MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform

June 2, 2020

MeMed Advances Diagnostic Solutions for COVID-19 Pandemic to Enable Enhanced Patient Management

May 25, 2020

Diagnostics Industry Veteran Dr. Frédéric Sweeney Joins MeMed as Chief Business Development Officer

Oct 29, 2019